NGSサンプル調製市場：製品、ワークフロー、技術、用途、エンドユーザー別-2025-2030年世界予測

NGSサンプル調製市場は2023年に24億米ドルと評価され、2024年には27億8,000万米ドルに達すると予測され、CAGR 16.01％で成長し、2030年には68億米ドルになると予測されています。

次世代シーケンス（NGS）サンプル調製には、抽出、精製、断片化、ライブラリー構築など、シーケンス用の核酸を調製するために必要なすべてのステップが含まれます。このセグメントは、サンプルの品質と下流の結果の精度を保証し、ゲノム研究、医療診断、個別化医療への応用を促進するため、NGSプロセス全体にとって不可欠です。臨床診断、感染症調査、がんゲノム解析における需要の高まりにより、NGS市場は大きな成長を遂げています。主な成長促進要因としては、より高いスループットと精度を実現する技術的進歩、ゲノム研究の急増、シーケンシングコストの低下などが挙げられます。さらに、サンプル調製プロセスにおける人工知能と自動化の統合は、効率性の向上とエラーの削減という市場プレイヤーにとって有利な機会をもたらします。しかし、市場の成長は、初期設定コストの高さ、規制の複雑さ、高度なNGSプラットフォームを稼働させるための熟練者の必要性といった課題に直面しています。中小企業にとっては、こうした障壁は特に大きな負担となるかもしれないです。このような課題にもかかわらず、技術革新は依然として堅調であり、標準化された使いやすいキットや、多様なサンプルをより効率的に処理できる消耗品の開発などが研究分野として期待されています。企業は、技術的能力を拡大し、マイクロ流体サンプル調製用ラボオンチップシステムなどの革新的アプローチを統合するために、パートナーシップや共同研究に注力することが推奨されます。競合情勢を考察すると、市場の競争は激しいもの、急速に進化していることがわかります。そこでは、常に技術の最先端にとどまり、カスタマイズ可能で費用対効果の高いソリューションを提供することが、ビジネスの成長には不可欠です。NGSサンプル調製市場の性質はダイナミックであり、継続的な技術的ブレークスルーとアプリケーションの拡大に牽引されています。

市場力学：急速に進化するNGSサンプル調製市場の主要市場インサイトを公開

NGSサンプル調製市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症の流行と早期診断ニーズの高まり
  • 新しい治療法の研究開発のためのNGSへの有利な投資状況
  • 持続可能な生産性を目指した農業分野でのNGSシーケンス技術の利用拡大
• 市場抑制要因
  • NGSサンプル調製プラットフォームの高コストとNGSサンプル調製中の汚染問題
• 市場機会
  • NGSサンプル調製プラットフォームの技術的進歩
  • NGSサンプル調製プラットフォーム開発のための民間・政府組織間の連携とパートナーシップの増加
• 市場の課題
  • 中・小規模ラボにおける熟練専門家の不足

ポーターの5つの力：NGSサンプル調製市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、NGSサンプル調製市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：NGSサンプル調製市場における外部からの影響の把握

外部マクロ環境要因は、NGSサンプル調製市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析NGSサンプル調製市場における競合情勢の把握

NGSサンプル調製市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスNGSサンプル調製市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、NGSサンプル調製市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨NGSサンプル調製市場における成功への道筋を描く

NGSサンプル調製市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の蔓延と早期診断の必要性の高まり
    • 新しい治療法の研究開発のためのNGSへの好ましい投資情勢
    • 持続可能な生産性のための農業におけるNGSシーケンシング技術の新たな利用
  • 抑制要因
    • NGSサンプル調製プラットフォームの高コストとNGSサンプル調製中の汚染問題
  • 機会
    • NGSサンプル調製プラットフォームの技術的進歩
    • 民間組織と政府組織間の協力とパートナーシップを強化し、NGSサンプル調製プラットフォームを開発する
  • 課題
    • 中規模および小規模の研究室では熟練した専門家が不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 NGSサンプル調製市場：製品別

• 試薬・消耗品
• ワークステーション

第7章 NGSサンプル調製市場：ワークフロー別

• DNA
  • ヒト全ゲノム配列解析（WGS）
  • ターゲットシーケンシング
  • 全エクソームシーケンス（WES）
• ライブラリの準備
• 品質管理
• RNA
  • 遺伝子発現解析
  • 全トランスクリプトーム配列解析
• ターゲットエンリッチメント
  • ターゲットシーケンス
  • ウェス
  • 全エクソームシーケンス（WES）

第8章 NGSサンプル調製市場：技術別

• イオン半導体シーケンシング
• ナノポアシーケンシング
• 合成によるシーケンシング（SBS）
• 単一分子リアルタイム（SMRT）シーケンシング

第9章 NGSサンプル調製市場：用途別

• 農業および動物調査
• 病気の診断
  • がん診断
  • 感染症診断
  • 生殖健康診断
• 創薬

第10章 NGSサンプル調製市場：エンドユーザー別

• 学術機関および研究センター
• 病院・クリニック
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのNGSサンプル調製市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のNGSサンプル調製市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのNGSサンプル調製市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Agilent、NGSサンプル調製ワークフローのユーザーエクスペリエンスを向上
  • INTEGRA BiosciencesがMiroculusを買収
  • Ultima GenomicsがNew England Biolabsと提携し、Ultimaシーケンサーの調査アプリケーションを拡大
  • QIAGENがVerogenの買収を完了、NGS技術によるヒト ID/法医学のリーダーシップを強化
  • アジレント、がん調査向け高性能NGSターゲットエンリッチメントワークフローの開発会社Avida Biomedの買収を発表
  • インテグレーテッドDNAテクノロジーズ、サル痘用の完全なNGSライブラリ準備ソリューションを発表
  • NGS KAPAターゲットエンリッチメント製品の発売
  • パーキンエルマー、ライブラリ準備を自動化するBioQule NGSシステムを発表
  • TecanのMagicPrep NGSのご紹介-NGSライブラリの準備ニーズに応えるウォークアウェイソリューション
  • ベックマン・コールター・ライフサイエンスとイルミナがBiomek NGeniuSシステムのアプリケーション開発契約を締結
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Applied Biological Materials Inc.
• Aurora Biomed Inc.
• Beckman Coulter by Danaher Corporation
• BGI Group
• Bio-Rad Laboratories, Inc.
• BioDynami
• Eppendorf SE
• Eurofins Genomics LLC
• F. Hoffmann-La Roche Ltd.
• FORMULATRIX, Inc.
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Macrogen Inc.
• Magen Biotechnology Co., Ltd.
• MCLAB
• Merck KGaA
• New England Biolabs, Inc.
• Novogene Co., Ltd.
• Oxford Nanopore Technologies PLC
• PerkinElmer Inc.
• Promega Corporation
• Psomagen, Inc.
• Qiagen N.V.
• SPT Labtech Ltd
• Standard BioTools Inc.
• Sysmex Corporation
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation
• Zymo Research Corporation

LIST OF FIGURES

• FIGURE 1. NGS SAMPLE PREPARATION MARKET RESEARCH PROCESS
• FIGURE 2. NGS SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NGS SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NGS SAMPLE PREPARATION MARKET DYNAMICS
• TABLE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HUMAN WHOLE GENOME SEQUENCING (WGS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQ, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE EXOME SEQUENCING (WES), BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SEQUENCING BY SYNTHESIS (SBS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 74. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 75. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 76. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 77. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 80. CANADA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES NGS SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 121. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 122. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 123. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 124. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 127. CHINA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 130. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 131. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 132. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 133. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 136. INDIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 284. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 285. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 286. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 287. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 288. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 289. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 290. ITALY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 291. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 292. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 298. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 299. NETHERLANDS NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 300. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 301. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 307. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 308. NIGERIA NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 309. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 310. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 311. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 312. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 314. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 316. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 317. NORWAY NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 318. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 319. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 320. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 321. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 322. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 323. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 324. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 325. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 326. POLAND NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 327. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 328. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 329. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 330. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 331. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 332. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 333. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 334. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY DISEASE DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 335. QATAR NGS SAMPLE PREPARATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 336. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 337. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 338. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY DNA, 2018-2030 (USD MILLION)
• TABLE 339. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY RNA, 2018-2030 (USD MILLION)
• TABLE 340. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, 2018-2030 (USD MILLION)
• TABLE 341. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 342. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 343. RUSSIA NGS SAMPLE PREPARATION MARKET SIZE, B

The NGS Sample Preparation Market was valued at USD 2.40 billion in 2023, expected to reach USD 2.78 billion in 2024, and is projected to grow at a CAGR of 16.01%, to USD 6.80 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation encompasses all necessary steps to prepare nucleic acids for sequencing, including extraction, purification, fragmentation, and library construction. This segment is indispensable to the overall NGS process, as it ensures sample quality and the accuracy of downstream results, facilitating applications in genomic research, medical diagnostics, and personalized medicine. With a rising demand in clinical diagnostics, infectious disease research, and cancer genomics, the NGS sample preparation market is witnessing significant growth. Key growth drivers include technological advancements delivering higher throughput and accuracy, a surge in genomic research, and the decreasing cost of sequencing. Additionally, the integration of artificial intelligence and automation in sample preparation processes presents lucrative opportunities for market players to enhance efficiency and reduce errors. However, market growth faces challenges such as the high initial setup cost, regulatory complexities, and the need for highly skilled personnel to run sophisticated NGS platforms. Small and medium-sized enterprises may find these barriers particularly prohibitive. Despite these challenges, innovation remains robust, with potential research areas including the development of standardized, user-friendly kits and consumables capable of handling diverse samples with greater efficiency. Companies are encouraged to focus on partnerships and collaborations to expand technological capabilities and integrate innovative approaches such as lab-on-a-chip systems for microfluidic sample preparation. Insight into the market reveals a competitive yet rapidly evolving landscape where staying at the forefront of technology and offering customizable and cost-effective solutions are vital for business growth. The nature of the NGS sample preparation market is dynamic, driven by continuous technological breakthroughs and an expanding array of applications, suggesting a promising future with opportunities for stakeholders willing to adapt and innovate accordingly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS Sample Preparation Market

The NGS Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious diseases and rising need for early disease diagnosis
  • Favorable investment landscape in NGS for the research and development of new treatments
  • Emerging use of NGS sequencing technology in agriculture for sustainable productivity
• Market Restraints
  • High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
• Market Opportunities
  • Technological advancement in NGS sample preparation platforms
  • Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
• Market Challenges
  • Limited availability of skilled professionals in medium and small size laboratories

Porter's Five Forces: A Strategic Tool for Navigating the NGS Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS Sample Preparation Market

A detailed market share analysis in the NGS Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS Sample Preparation Market

A strategic analysis of the NGS Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials Inc., Aurora Biomed Inc., Beckman Coulter by Danaher Corporation, BGI Group, Bio-Rad Laboratories, Inc., BioDynami, Eppendorf SE, Eurofins Genomics LLC, F. Hoffmann-La Roche Ltd., FORMULATRIX, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen Inc., Magen Biotechnology Co., Ltd., MCLAB, Merck KGaA, New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, Psomagen, Inc., Qiagen N.V., SPT Labtech Ltd, Standard BioTools Inc., Sysmex Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the NGS Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Reagents & Consumables and Workstations.
• Based on Workflow, market is studied across DNA, Library Preparation, Quality Control, RNA, and Target Enrichment. The DNA is further studied across Human Whole Genome Sequencing (WGS), Targeted Sequencing, and Whole Exome Sequencing (WES). The RNA is further studied across Gene Expression Analysis and Whole Transcriptome Sequencing. The Target Enrichment is further studied across Targeted Seq, WES, and Whole Exome Sequencing (WES).
• Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis (SBS), and Single-molecule real-time (SMRT) Sequencing.
• Based on Application, market is studied across Agricultural & Animal Research, Disease Diagnostics, and Drug Discovery. The Disease Diagnostics is further studied across Cancer Diagnostics, Infectious Disease Diagnostics, and Reproductive Health Diagnostics.
• Based on End-User, market is studied across Academic Institutes and Research Centers, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious diseases and rising need for early disease diagnosis
    • 5.1.1.2. Favorable investment landscape in NGS for the research and development of new treatments
    • 5.1.1.3. Emerging use of NGS sequencing technology in agriculture for sustainable productivity
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of NGS sample preparation platforms and contamination issues during NGS sample preparation
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in NGS sample preparation platforms
    • 5.1.3.2. Increasing collaboration and partnership among private and government organizations to develop NGS sample preparation platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled professionals in medium and small size laboratories
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. NGS Sample Preparation Market, by Product

• 6.1. Introduction
• 6.2. Reagents & Consumables
• 6.3. Workstations

7. NGS Sample Preparation Market, by Workflow

• 7.1. Introduction
• 7.2. DNA
  • 7.2.1. Human Whole Genome Sequencing (WGS)
  • 7.2.2. Targeted Sequencing
  • 7.2.3. Whole Exome Sequencing (WES)
• 7.3. Library Preparation
• 7.4. Quality Control
• 7.5. RNA
  • 7.5.1. Gene Expression Analysis
  • 7.5.2. Whole Transcriptome Sequencing
• 7.6. Target Enrichment
  • 7.6.1. Targeted Seq
  • 7.6.2. WES
  • 7.6.3. Whole Exome Sequencing (WES)

8. NGS Sample Preparation Market, by Technology

• 8.1. Introduction
• 8.2. Ion Semiconductor Sequencing
• 8.3. Nanopore Sequencing
• 8.4. Sequencing by Synthesis (SBS)
• 8.5. Single-molecule real-time (SMRT) Sequencing

9. NGS Sample Preparation Market, by Application

• 9.1. Introduction
• 9.2. Agricultural & Animal Research
• 9.3. Disease Diagnostics
  • 9.3.1. Cancer Diagnostics
  • 9.3.2. Infectious Disease Diagnostics
  • 9.3.3. Reproductive Health Diagnostics
• 9.4. Drug Discovery

10. NGS Sample Preparation Market, by End-User

• 10.1. Introduction
• 10.2. Academic Institutes and Research Centers
• 10.3. Hospitals & Clinics
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Sample Preparation Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific NGS Sample Preparation Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa NGS Sample Preparation Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Agilent enhances user experience in NGS sample preparation workflow
  • 14.3.2. INTEGRA Biosciences Acquires Miroculus
  • 14.3.3. Ultima Genomics Partners with New England Biolabs to Expand Research Applications on Ultima Sequencers
  • 14.3.4. QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies
  • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
  • 14.3.6. Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox
  • 14.3.7. NGS KAPA Target Enrichment Product Launch
  • 14.3.8. PerkinElmer Launches BioQule NGS System to Automate Library Preparation
  • 14.3.9. Introducing Tecan's MagicPrep NGS - the walkaway solution for your NGS library prep needs
  • 14.3.10. Beckman Coulter Life Sciences and Illumina Enter Into Application Development Agreement for the Biomek NGeniuS System
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied Biological Materials Inc.
• 3. Aurora Biomed Inc.
• 4. Beckman Coulter by Danaher Corporation
• 5. BGI Group
• 6. Bio-Rad Laboratories, Inc.
• 7. BioDynami
• 8. Eppendorf SE
• 9. Eurofins Genomics LLC
• 10. F. Hoffmann-La Roche Ltd.
• 11. FORMULATRIX, Inc.
• 12. Illumina, Inc.
• 13. Integrated DNA Technologies, Inc.
• 14. Macrogen Inc.
• 15. Magen Biotechnology Co., Ltd.
• 16. MCLAB
• 17. Merck KGaA
• 18. New England Biolabs, Inc.
• 19. Novogene Co., Ltd.
• 20. Oxford Nanopore Technologies PLC
• 21. PerkinElmer Inc.
• 22. Promega Corporation
• 23. Psomagen, Inc.
• 24. Qiagen N.V.
• 25. SPT Labtech Ltd
• 26. Standard BioTools Inc.
• 27. Sysmex Corporation
• 28. Takara Bio Inc.
• 29. Tecan Trading AG
• 30. Thermo Fisher Scientific Inc.
• 31. Twist Bioscience Corporation
• 32. Zymo Research Corporation